132 related articles for article (PubMed ID: 19567472)
21. The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA.
Lai HK; Borden KL
Oncogene; 2000 Mar; 19(13):1623-34. PubMed ID: 10763819
[TBL] [Abstract][Full Text] [Related]
22. The key role of PML in IFN-α induced cellular senescence of human mesenchymal stromal cells.
Fu S; Wei J; Wang G; Wang B; Wang Y; Lai X; Huang H
Int J Oncol; 2015 Jan; 46(1):351-9. PubMed ID: 25354534
[TBL] [Abstract][Full Text] [Related]
23. Lack of telomerase activity in lung carcinoids is dependent on human telomerase reverse transcriptase transcription and alternative splicing and is associated with long telomeres.
Zaffaroni N; Villa R; Pastorino U; Cirincione R; Incarbone M; Alloisio M; Curto M; Pilotti S; Daidone MG
Clin Cancer Res; 2005 Apr; 11(8):2832-9. PubMed ID: 15837730
[TBL] [Abstract][Full Text] [Related]
24. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.
Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Haruma K; Chayama K; Yasui W; Tahara E
Int J Oncol; 2001 Sep; 19(3):507-12. PubMed ID: 11494028
[TBL] [Abstract][Full Text] [Related]
25. PML3 interacts with TRF1 and is essential for ALT-associated PML bodies assembly in U2OS cells.
Yu J; Lan J; Wang C; Wu Q; Zhu Y; Lai X; Sun J; Jin C; Huang H
Cancer Lett; 2010 May; 291(2):177-86. PubMed ID: 19900757
[TBL] [Abstract][Full Text] [Related]
26. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.
Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S
J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989
[TBL] [Abstract][Full Text] [Related]
27. Serum-dependent expression of promyelocytic leukemia protein suppresses propagation of influenza virus.
Iki S; Yokota S; Okabayashi T; Yokosawa N; Nagata K; Fujii N
Virology; 2005 Dec; 343(1):106-15. PubMed ID: 16154611
[TBL] [Abstract][Full Text] [Related]
28. Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT.
Gessner A; Thomas M; Castro PG; Büchler L; Scholz A; Brümmendorf TH; Soria NM; Vormoor J; Greil J; Heidenreich O
Leukemia; 2010 Oct; 24(10):1751-9. PubMed ID: 20686504
[TBL] [Abstract][Full Text] [Related]
29. The structure and function of telomerase reverse transcriptase.
Autexier C; Lue NF
Annu Rev Biochem; 2006; 75():493-517. PubMed ID: 16756500
[TBL] [Abstract][Full Text] [Related]
30. Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation.
Pendino F; Flexor M; Delhommeau F; Buet D; Lanotte M; Segal-Bendirdjian E
Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6662-7. PubMed ID: 11371621
[TBL] [Abstract][Full Text] [Related]
31. Feedback regulation of telomerase reverse transcriptase: new insight into the evolving field of telomerase in cancer.
Wu XQ; Huang C; He X; Tian YY; Zhou DX; He Y; Liu XH; Li J
Cell Signal; 2013 Dec; 25(12):2462-8. PubMed ID: 23993966
[TBL] [Abstract][Full Text] [Related]
32. The promyelocytic leukemia protein functions as a negative regulator of IFN-gamma signaling.
Choi YH; Bernardi R; Pandolfi PP; Benveniste EN
Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18715-20. PubMed ID: 17121994
[TBL] [Abstract][Full Text] [Related]
33. Expression of telomerase RNA template, but not telomerase reverse transcriptase, is limiting for telomere length maintenance in vivo.
Chiang YJ; Hemann MT; Hathcock KS; Tessarollo L; Feigenbaum L; Hahn WC; Hodes RJ
Mol Cell Biol; 2004 Aug; 24(16):7024-31. PubMed ID: 15282303
[TBL] [Abstract][Full Text] [Related]
34. CEBP factors regulate telomerase reverse transcriptase promoter activity in whey acidic protein-T mice during mammary carcinogenesis.
Kumar M; Witt B; Knippschild U; Koch S; Meena JK; Heinlein C; Weise JM; Krepulat F; Kuchenbauer F; Iben S; Rudolph KL; Deppert W; Günes C
Int J Cancer; 2013 May; 132(9):2032-43. PubMed ID: 23023397
[TBL] [Abstract][Full Text] [Related]
35. Promyelocytic leukemia protein-induced growth suppression and cell death in liver cancer cells.
Son SH; Yu E; Choi EK; Lee H; Choi J
Cancer Gene Ther; 2005 Jan; 12(1):1-11. PubMed ID: 15529177
[TBL] [Abstract][Full Text] [Related]
36. IFN-alpha-induced apoptosis in hepatocellular carcinoma involves promyelocytic leukemia protein and TRAIL independently of p53.
Herzer K; Hofmann TG; Teufel A; Schimanski CC; Moehler M; Kanzler S; Schulze-Bergkamen H; Galle PR
Cancer Res; 2009 Feb; 69(3):855-62. PubMed ID: 19141642
[TBL] [Abstract][Full Text] [Related]
37. Cellular functions of the dual-targeted catalytic subunit of telomerase, telomerase reverse transcriptase--potential role in senescence and aging.
Ale-Agha N; Dyballa-Rukes N; Jakob S; Altschmied J; Haendeler J
Exp Gerontol; 2014 Aug; 56():189-93. PubMed ID: 24583100
[TBL] [Abstract][Full Text] [Related]
38. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.
Liu JH; Liu CC; Yen CC; Gau JP; Wang WS; Tzeng CH
Int J Cancer; 2009 Jul; 125(1):71-7. PubMed ID: 19291793
[TBL] [Abstract][Full Text] [Related]
39. Differential TERT promoter methylation and response to 5-aza-2'-deoxycytidine in acute myeloid leukemia cell lines: TERT expression, telomerase activity, telomere length, and cell death.
Pettigrew KA; Armstrong RN; Colyer HA; Zhang SD; Rea IM; Jones RE; Baird DM; Mills KI
Genes Chromosomes Cancer; 2012 Aug; 51(8):768-80. PubMed ID: 22517724
[TBL] [Abstract][Full Text] [Related]
40. Regulation of telomere length and homeostasis by telomerase enzyme processivity.
D'Souza Y; Lauzon C; Chu TW; Autexier C
J Cell Sci; 2013 Jan; 126(Pt 2):676-87. PubMed ID: 23178942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]